Nephros, Inc. (NEPH) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nephros, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.588 -- 00:00:06.013 Good day and welcome to the NEPHRO's Inc. Second Quarter 2025 Financial Results 00:00:06.013 -- 00:00:10.077 Conference Call. All participants will be in listen-only mode. 00:00:10.077 -- 00:00:14.222 Should you need assistance, please signal a conference specialist by pressing the star 00:00:14.222 -- 00:00:19.367 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:19.367 -- 00:00:24.372 questions. To ask a question, you may press star then one on your telephone keypad. 00:00:24.372 -- 00:00:28.636 To withdraw your question, please press star then two. 00:00:28.636 -- 00:00:32.898 Please note this event is being recorded. I would now like to turn the conference over 00:00:32.898 -- 00:00:37.630 to Kieran Smith, Investor Relations. Please go ahead. 00:00:37.630 -- 00:00:39.836 Thank you, Megan. Good afternoon, everyone. 00:00:39.836 -- 00:00:44.929 This is Kieran Smith with PCG Advisory. Thank you all for participating in NEPHRO's 00:00:44.929 -- 00:00:50.026 second quarter 2025 conference call. Before we begin, I would like to caution that 00:00:50.026 -- 00:00:53.550 comments made during this conference call by management will contain forward-looking 00:00:53.550 -- 00:00:57.636 statements regarding the operations and future results of Nefros. 00:00:57.636 -- 00:01:01.921 I encourage you to review Nefros' filings with the Securities and Exchange Commission, 00:01:01.921 -- 00:01:06.948 including, without limitation, the company's Forms 10-K and 10-Q, which identify 00:01:06.948 -- 00:01:11.974 specific factors that may cause actual results or events to differ materially from 00:01:11.974 -- 00:01:14.281 those described in the forward-looking statements. 00:01:14.281 -- 00:01:19.309 Factors ...